Tonix Pharmaceuticals Holding Corp.
Nasdaq · Healthcare · Pharmaceutical Preparations · Berkeley Heights, NJ
TNXP chart
What traders are saying about $TNXP
Latest postsTonix Pharmaceuticals Holding Corp. news
- Tonix Pharmaceuticals presents data from RELIEF, RESILIENT studies of Tonmya
TipRanks ·
- Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain
Yahoo Finance ·
- Tonix Pharmaceuticals Sets Nov. 9 Date for Third-Quarter 2026 Financial Results Call
citybuzz - ·
- CCORF Initiates Tonix Pharmaceuticals(TNXP.US) With Buy Rating, Announces Target Price $18
Moomoo ·
- Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by Canaccord Genuity Group
MarketBeat ·
- Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
Yahoo Finance ·
- Tonix Pharmaceuticals Holding Corp. Estimates – BOATS:TNXP
TradingView ·
- A New Fibromyalgia Drug Deal Reaches 21 Million More Medicare Lives. Her Own Plan Could Still Decide What She Pays
247wallst.com ·
- Tonix Pharmaceuticals Holding (NasdaqGS:TNXP) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
Yahoo Finance ·
- Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
Yahoo Finance ·
Tonix Pharmaceuticals Holding Corp. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $13.1M | $10.1M | $7.8M | – |
| Net income | -$124.0M | -$130.0M | -$116.7M | -$110.2M |
| Diluted EPS | $-14.57 | $-176.60 | $-14720.25 | $-20.01 |
| Total assets (year end) | $277.2M | $162.9M | $154.5M | $225.7M |
| Cash and equivalents (year end) | $207.6M | $98.8M | $24.9M | $120.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tonix Pharmaceuticals Holding Corp.
- Ticker
- TNXP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Berkeley Heights, NJ
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1430306
- Former names
- TAMANDARE EXPLORATIONS INC.
Frequently asked questions
What exchange is Tonix Pharmaceuticals Holding Corp. listed on?
Tonix Pharmaceuticals Holding Corp. trades on the Nasdaq under the ticker symbol TNXP.
What industry is Tonix Pharmaceuticals Holding Corp. in?
Tonix Pharmaceuticals Holding Corp. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Tonix Pharmaceuticals Holding Corp. headquartered?
Tonix Pharmaceuticals Holding Corp.'s business address on file with the SEC is in Berkeley Heights, NJ.
When does Tonix Pharmaceuticals Holding Corp.'s fiscal year end?
Tonix Pharmaceuticals Holding Corp.'s fiscal year ends on December 31.
How much revenue did Tonix Pharmaceuticals Holding Corp. report?
Tonix Pharmaceuticals Holding Corp. reported $13.1M in revenue for calendar year 2025, according to its SEC filings.